

Joseph D. Keegan | Labcyte Inc.





















































LABCYTE


APPLICATIONS
PRODUCTS
TECHNOLOGY
NEWS / EVENTS
RESOURCES
SUPPORT
COMPANY




BLOG | CAREERS | CONTACT US |
REGISTER / SIGN IN


Search










APPLICATIONS OVERVIEW
Echo Liquid Handling Applications



Drug Discovery
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management


Cancer Research
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics


Genomic Research

Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology






LIQUID HANDLING
Liquid Handlers Overview
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler



AUTOMATION
Automation Overview
Access™ Laboratory Workstation

Tempo™ Automation Control Software


SOFTWARE APPLICATIONS
Software Overview
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat


CONSUMABLES
Consumables Overview
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir





Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Direct Dilution





Labcyte BLOG
Upcoming Events

Press Releases
Labcyte in the News
Labcyte Community






JALA Special Issue on ADE
Publications
Articles and Other Media
Application Notes
Posters and Presentations
Webinars
Videos
Customer Profiles
Core Labs





Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Integration Models
Service and Maintenance
Request Information





About Us
Echo® Acoustic Technology
Leadership Team
Careers
Contact and Location
Privacy Policy









 

LABCYTE
MENU

Search




search



REQUEST INFO







 




Home
Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH

Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation

Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community


Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Integration Models
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Careers
Contact and Location
Privacy Policy

REGISTER / SIGN IN










HOME | COMPANY | LEADERSHIP TEAM | Joseph D. Keegan, Ph.D., Chairman of the Board


Joseph D. Keegan, Ph.D.Chairman of the Board





                    Dr. Keegan has more than 30 years of experience in life science businesses. Most recently as CEO at ForteBio, Inc.
                    he led the Series C financing which raised $25M, established product development and sales strategies that
                    resulted in 2007-11 compounded annual revenue growth of 45%, and exited the company through its sale to Pall
                    Corporation at 6x ttm revenue. During his 9 year tenure at Molecular Devices Corporation, Dr. Keegan grew the
                    company's revenues from $30M to $200M through internal growth and acquisitions. In early 2007, he oversaw its
                    acquisition by MDS for $615M. Dr. Keegan joined MDC from Becton Dickinson and Company where he served as
                    President of Worldwide Tissue Culture and Vice President, General Manager of Worldwide Flow Cytometry.
                    Prior to Becton Dickinson, Dr. Keegan was Vice President of the Microscopy and Scientific Instruments Division of Leica,
                    Inc. He currently serves on the Board of Directors of ALSSA as Chairman, Labcyte Corporation as Chairman,
                    Response Biomedical Corp (RBM:Toronto), Seahorse Bioscience Inc., Stereotaxis, Inc. (Nasdaq: STXS) and the San Francisco Opera.
                    Dr. Keegan holds a B.A. in Chemistry from Boston University and a Ph.D. in Physical Chemistry from Stanford University.
                


 

Executive Officers
Board of Directors








Mark D. Fischer-Colbrie 
                                    President,Chief Executive Officer
                                






Richard Ellson
                                    Chief Technology Officer
                                






Chris Grimley
                                    Vice Marketing
                                






Keith Love
                                    Vice President,Manufacturing
                                






Michael F. Miller 
                                    Vice President,Product Development
                                






Tammy L. Cameron
                                    Vice President,Product Development
                                











Joseph D. Keegan, Ph.D.,
                                    Chairman of the Board
                                






Mark D. Fischer-Colbrie
                                    President,Chief Executive Officer
                                






Richard Ellson
                                    Chief Technology Officer
                                






JonathanMacQuitty, Ph.D.,
                                    Director
                                






Sandra Panem, Ph.D., 
                                    Director
                                






Joseph H. Smith, Esq.,
                                    Director
                                






Craig C. Taylor
                                    Director
                                












Labcyte in the News:


Acoustic Liquid Handling: Using Sound to Dispense Liquids - by Angelo DePalma, Lab Manager
A new breed of scientist, with brains of silicon - by John Bohannon on Science Mag
Application note: The reliability of assay-ready plates for cell-based screening enabled by the Echo® 550 Liquid Handler
High Throughput Screening – Accelerating drug discovery efforts - by Jack Rudd, Sr. Editor at Technology Networks
Kudos to our first place winner Jasmine Temple and her @nyuniversity team Jef Boeke, Michael Shen & Leslie Mitchell for Sunset at the End!






















APPLICATIONS
Echo Applications Overview


PRODUCTS
Echo® Liquid Handlers
Labcyte Automation
Echo Software
Labcyte Consumables


TECHNOLOGY
Echo Acoustic Liquid Handling
Dynamic Fluid Analysis™
Direct Dilution


IN THE NEWS
Labcyte in the News
Labcyte Blog


COMPANY
Careers
Contact / Location Info
Request Information







LABCYTE INC. | 170 Rose Orchard Way | San Jose, CA 95134 | USA

TEL:
+1 408 747-2000
SALES:
+1 408 542-7855
FAX:
+1 408 747-2010
EMAIL:
info-us@labcyte.com



















© 2017 LABCYTE INC. ALL RIGHTS RESERVED. Labcyte® and Echo® are registered trademarks of Labcyte Inc., in the U.S. and/or other countries.

DISCLAIMER
PRIVACY POLICY
COPYRIGHT









 

BROCHURE



Echo®Liquid Handlers

Acoustic liquid handlingtechnology
DOWNLOAD







Labcyte Inc. | 170 Rose Orchard Way | San Jose, CA 95134, USA
            

twitter
linkedin
youtube
vimeo
google plus
facebook



                © 2017 LABCYTE INC. ALL RIGHTS RESERVED.
            

























Pall ForteBio :: Management Team



















 



 

Login  |  Register  |  Shop



















ProductsOctet SystemsOctet RED96eOctet HTXOctet RED384Octet QK384Octet RED96Octet QKeOctet K2Octet SoftwareAutomationAccessoriesBlItz SystemPioneer SystemsDip and Read BiosensorsAHC - Anti-Human Fc CaptureAHQ - Anti-Human IgG QuantitationAMC - Anti-Mouse Fc CaptureAMQ - Anti-Murine IgG QuantitationAPS - AminopropylsilaneAR2G - Amine Reactive 2nd GenerationFAB2G - Anti-Human Fab-CH1 2nd GenerationGST - Anti-GSTHIS1K - Anti-Penta-HISHIS2 - Anti-HISNTA - Ni-NTAProA - Protein AProG - Protein GProL - Protein LSA - StreptavidinSAX - High Precision StreptavidinSSA - Super StreptavidinReady BLI Detection KitsCHO Host Cell ProteinResidual Protein AApplicationsApplications OverviewKinetic CharacterizationDip and Read ELISA AssayBioprocessingAntibody Titer and Protein QuantitationHost Cell Protein DetectionResidual Protein ASmall Molecules & Small PeptidesVaccines & VirusesAssay DevelopmentBiopharm PortalPortal HomeTarget IdentificationLead IdentificationLead OptimizationPKPDUpstream ProcessingDownstream & MfgVaccines & VirusesSmall MoleculesPublication SearchLearningDownloadable LiteratureLiterature ReferencesUpcoming WorkshopsWebinarsBLI TechnologyPioneer SPR PrinciplesFeatured HighlightsNewsletter ArchivesOrderingGeneral Ordering InformationOctet Instrument PlatformSoftwareService and Training OptionsValidation and ComplianceAccessories and Reagents384TW MicroplatesSidekick ShakerPioneer SystemsAccessories and AdaptersBiosensorsConsumablesServiceDip and Read BiosensorsAHC - Anti-Human Fc CaptureAHQ - Anti-Human IgG QuantitationAMC - Anti-Mouse Fc CaptureAMQ - Anti-Murine IgG QuantitationAPS - AminopropylsilaneAR2G - Amine Reactive 2nd GenerationFAB2G - Anti-Human Fab-CH1 2nd GenerationGST - Anti-GSTHIS1K - Anti-Penta-HISHIS2 - Anti-HISNTA - Ni-NTAProA - Protein AProG - Protein GProL - Protein LSA - StreptavidinSAX - High PrecisionStreptavidinSSA - Super StreptavidinReady BLI Detection KitsCHO Host Cell ProteinResidual Protein ASoftwareService ContractsValidation and ComplianceSupportSupport CenterGeneral FAQsCustomer KnowledgebaseSoftware Updates and User GuidesOnline Technical SupportOnline General QuestionsMaintenance & ServiceRegister a ProductAboutAbout UsNewsUpcoming EventsPast EventsCareer OpportunitiesContact UsQuote 






 

Management Team

 



About UsNewsUpcoming EventsPast EventsCareer OpportunitiesContact Us 







Joseph D. Keegan, Ph.D.
President and CEO
Dr.  Keegan has more than 25 years of experience managing life science tools  businesses. Since joining ForteBio, Inc. in 2007 he led the Series C  financing which raised $25M and established product development and  sales strategies that have resulted in compounded annual revenue growth  of 45%. During his 9-year tenure at Molecular Devices Corporation, Dr.  Keegan grew the company's revenues from $30 million to $190 million  through internal growth and acquisitions. In early 2007, he oversaw its  acquisition by MDS for $615 million. Dr. Keegan joined MDC from Becton  Dickinson and Company where he served as President of Worldwide Tissue  Culture and Vice President, General Manager of Worldwide Flow Cytometry.  Prior to Becton Dickinson, Dr. Keegan was Vice President of the  Microscopy and Scientific Instruments Division of Leica, Inc. He  currently serves on the Board of Directors of ALSSA as Chairman,  Seahorse Bioscience Inc., Stereotaxis, Inc. (Nasdaq: STXS) and Response  Biomedical Corp (RBM:Toronto). Dr. Keegan holds a Ph.D. in Physical  Chemistry from Stanford University.






Jack H. Fuchs
Chief Financial Officer
Jack brings a wide range of business and entrepreneurial skills to ForteBio including a deep understanding of marketing and sales, business development, finance and corporate strategy. As an entrepreneur, he has held Vice President, Marketing, Business Development, and Sales positions at a number of private companies, including IPWireless, a 120-person broadband wireless company that was successfully sold to a strategic buyer in 2007. Previously, Jack held several senior positions with increasing responsibility at Becton Dickinson & Company including Vice President, e-Business; North American Business Leader and Vice President Worldwide Marketing, Injection Systems; and Director of Corporate Planning. Earlier in his career, Jack was an Engagement Manager with McKinsey & Company, where his client focus was the healthcare industry, including technology strategy for pharmaceutical businesses and operational strategy for medical device businesses. He has an AB in Engineering Sciences from Dartmouth College and received his MBA from Stanford University.






Terry L. Salyer
Vice President of Sales
Terry’s experience in the life sciences industry encompasses domestic sales, finance and marketing in addition to her leadership role in international sales.  She joined ForteBio from Eksigent Technologies, where as Vice President of Worldwide Sales and Service Terry developed a global sales organization and commercial structure for this capital equipment company. Prior to that, as Director of Sales at Molecular Devices, Terry was responsible for the company’s Life Sciences, Cellular Neuroscience, and Threshold Divisions.  During her ten years at Molecular Devices, Terry was also Western Regional Manager of the Life Sciences Division. She holds a BS in Biotechnology from Minnesota State University at Mankato.






Christopher M. Silva
Vice President, Marketing
Chris brings to ForteBio a strong track record of product and business growth in the life sciences industry. Prior to joining ForteBio, he was Director of Strategic and Worldwide Product Marketing at Molecular Devices, a business unit of MDS, Inc. At Molecular Devices, he led three product families (including the SpectraMax microplate reader, the company's largest product line), and doubled revenues to greater than $70 million in five years. Chris began his career as a founding member of Kairos Scientific Inc. He holds a BS in molecular biology from San Jose State University and an MBA from Santa Clara University. Chris holds four patents and is co-author of multiple peer-reviewed journal articles.






Robert Wicke
Vice President of Product Development and Operations
Robert joined ForteBio in 2007 from Molecular Devices Corporation, where he was Vice President of Product Development, managing over 80 engineers. He was on the executive team there that helped the $615 million acquisition by MDS. Previously he was at Axon Instruments, Inc. as Vice President of Engineering, where he was part of the $170 million acquisition by Molecular Devices. In addition, Robert was a founding member of Anyware Fast, Inc., working closely with Sun Microsystems on creating the original Java platform and the XIL imaging suite. He has more than 20 years of professional software engineering experience, product development and over 10 years of executive business management in instrumentation companies; he has helped release over a dozen major successful products, including the Genepix microarray scanner, Axoclamp electrophysiology amplifiers and pClamp software, Metamorph for cellular imaging, Acuity for bioinformatics, and the FLIPR Tetra for fluorescence screening. Robert received a BA in Computer and Information Sciences and a BA in Mathematics from Drew University, NJ and an MS in Computer and Information Sciences, specializing in 3D mathematical visualization techniques from the University of Oregon. 






Lei Wu, Ph.D.
Vice President, China Operations
Dr. Wu brings strong leadership in both technology and business with extensive experience in strategy, management, operations, manufacturing, and international experience in the Chinese biotechnology market. Before he joined ForteBio, Dr. Wu co-founded AVIVA Biosciences in 1999 with technology transfer from Tsinghua University in China and held a variety of executive positions including COO, VP of system development and VP of manufacturing. Dr. Wu and his team developed planar patch-clamp technology which has won the award of Breakthrough Innovation in Science by BIOCOM in year 2002. Between 1995 and 1999, Dr. Wu worked at Nanogen where he was instrumental in the development of APEX biochip and instrument. He was responsible for development of the Lab-on-a-Chip at Nanogen that was published in Nature Biotechnology and selected as Breakthrough of the Year by SCIENCE magazine in 1998. He is inventor and or co-inventor on 18 issued patents, 12 pending patent applications and 32 publications. Dr. Wu received a Ph.D. in Physics from the University of Chicago and post-doctoral training at Massachusetts Institute Technology (MIT).




 




  







ProductsApplicationsBiopharm PortalLearningOrderingSupportAboutQuote 



Careers
Company
Site Map
Terms of Use
Privacy Policy












Pall ForteBio develops and markets advanced analytical systems powered by BLI and SPR technology for unique real-time, label-free insights into molecular interactions, providing information on affinity, kinetics and concentration to accelerate biotherapeutic drug discovery, development and manufacturing.


© 2017 Pall Corporation. All Rights Reserved.



















Joseph D. Keegan Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Joseph D. Keegan Ph.D.
Board Member at Interpace Diagnostics Group, Inc.


View Full Profile
Are you Joseph D. Keegan Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Joseph D. Keegan Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Joseph D. Keegan Ph.D.'s  network and community.
												FOLLOW changes in Joseph D. Keegan Ph.D.'s employment and money-in-motion.
												CONNECT with Joseph D. Keegan Ph.D. through your network of contacts.
												








Joseph D. Keegan Ph.D.'s Executive Work History


Current


Board Member, 
Interpace Diagnostics Group, Inc.


Past
To view Joseph D. Keegan Ph.D.'s complete executive work history, sign up now
Education


														 Ph.D., 
															Stanford University


														 B.A., 
															Boston University


Age
63

 
 


Joseph D. Keegan Ph.D.'s Biography



Joseph Keegan, Ph.D. was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee and our Nominating and Corporate Governance Committee. Dr. Keegan has more than 30 years of experience in life science businesses. From 2007 to 2012, when it was sold to Pall Corporation, Dr. Keegan was CEO at ForteBio, Inc., a life science tool company, where he helped to lead a financing round and established product development and sales strategies for that company. From 1998 to 2007, Dr. Keegan was CEO at Molecular Devices Corporation (NASDAQ: MDCC), a provider of bioanalytical measurement systems, softw ...
(Read More)

			Joseph Keegan, Ph.D. was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee and our Nominating and Corporate Governance Committee. Dr. Keegan has more than 30 years of experience in life science businesses. From 2007 to 2012, when it was sold to Pall Corporation, Dr. Keegan was CEO at ForteBio, Inc., a life science tool company, where he helped to lead a financing round and established product development and sales strategies for that company. From 1998 to 2007, Dr. Keegan was CEO at Molecular Devices Corporation (NASDAQ: MDCC), a provider of bioanalytical measurement systems, software and consumables, where Dr. Keegan grew the company both internally and through acquisitions. From 1992 to 1998, Dr. Keegan worked at Becton Dickinson and Company, a medical technology company that manufactures and sells medical devices and instrument systems, where he served as President of Worldwide Tissue Culture and Vice President, General Manager of Worldwide Flow Cytometry. From 1988 to 1992, Dr. Keegan was Vice President of the Microscopy and Scientific Instruments Division of Leica, Inc., a life science tool and semiconductor equipment provider. He currently serves on the boards of directors of Courtagen Life Sciences, Labcyte Corporation (as chairman), Nanomedical Diagnositics, Inc., Optofluidics, Inc., Unchained Labs, Inc., Wasatch Microfluidics, Inc., and the San Francisco Opera. Dr. Keegan holds a B.A. in Chemistry from Boston University and a Ph.D. in Physical Chemistry from Stanford University.
 
Dr. Keegan's specific qualifications and skills in the areas of life science businesses, product development and sales strategies led the Board to conclude that Dr. Keegan should serve as a director of the Company.
		
Source: Interpace Diagnostics Group, Inc. on 04/28/2017
		
	

 






Sign up for Equilar Atlas and view Joseph D. Keegan Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Joseph D. Keegan Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Joseph D. Keegan Ph.D.'s  network and community.
												FOLLOW changes in Joseph D. Keegan Ph.D.'s employment and money-in-motion.
												CONNECT with Joseph D. Keegan Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Joseph D. Keegan Ph.D.


















Joseph D. Keegan Ph.D.'s Connections (65)





Sign up now to view Joseph D. Keegan Ph.D.'s 65 connections »









Clinton H. Severson
Chairman of the Board and Chief Executive Officer, Abaxis, Inc.









Christopher D. Alafi
Board Member, Intra-Cellular Therapies, Inc.









Frank J. Cheng
Former Senior Vice President, Marketing and Business Development, Stereotaxis, Inc.









David A. Giffin
Vice President, Human Resources, Stereotaxis, Inc.









Chris van Ingen
Former Board Member, Bruker Corporation









A. Blaine Bowman
Lead Independent Director, Illumina, Inc.









Martin C. Stammer
Chief Financial Officer, Stereotaxis, Inc.









Douglas M. Bruce
Former Chief Technology and Operations Officer, Stereotaxis, Inc.









Peter A. Thompson
Board Member, Adaptimmune Therapeutics









Stephen J. Sullivan
Chairman of the Board, Interpace Diagnostics Group, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Daniel A. DeMatteo
Executive Chairman, GameStop Corp.









David J. O'Connor
President and CEO, The Madison Square Garden Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993



















Keegan, Joseph D. - The Wall Street Transcript













































 





































Joseph D. Keegan
JOSEPH D. KEEGAN, PhD was appointed President and Chief Executive
Officer of the company effective March 30, 1998. From 1992 to 1998, Dr.
Keegan served in various positions at Becton Dickinson and Company, a
research and diagnostic company, including the positions of Vice
President, Sales and Service, Vice President, General Manager of the
Immunocytometry Systems Division and President of the Worldwide Tissue
Culture Business. From 1987 to 1992, he was employed by LEICA, Inc., a
microscope manufacturer, where he held various senior management
positions. Dr. Keegan holds a PhD in Chemistry from Stanford University.
Related Interviews:Joseph Keegan - Molecular Devices Corporation (mdcc)January 10, 2001Joseph Keegan - Molecular Devices Corporation (mdcc)October 05, 2000Joseph D. Keegan -  Molecular Devices Corporation (mdcc)December 14, 1998







CartLatest NewsJames Abate of Centre Asset Management Sees Consumer Demand Driving New Stock HighsMalcolm E. Polley of Stewart Capital and How to Play the Health Care StocksTimothy Biltz, CEO of Lumos Networks Identifies the Key Component for Future 5G NetworksThe Wall Street Transcript is a completely unique resource for investors and business researchers.Over 20,000 CEO, Equity Analyst and Money Manager InterviewsSubscribe now!Sign Up For Newsletter Weekly email with New In-Depth Interviews


Email: 



Most Popular InterviewsDelivering Long-Term Results with a Risk-Managed Growth FundJames A. Abate Published July 20, 2017 in Investing StrategiesCompanies covered: AMAT JNJ COH RL COG NVDA ADBE ATVI KLAC AMZN NFLX GOOG FB GLW MU 005930 000660 WFM JWN CMG GPS EQT RICE SPLS Buy ($25)Finding Investments with Favorable Risk and Reward OpportunitiesHenry  Beukema Published July 19, 2017 in Investing StrategiesCompanies covered: ORCL MSFT NSRGY AMZN WFM LRLCY AGN LNR Buy ($25)Better Returns and Lower Risk in the Midcap SpaceMalcolm E. Polley Published July 18, 2017 in Investing StrategiesCompanies covered: PRAA HURN FII FL NKE AMZN WFM WBA RAD Buy ($25)Most Popular ReportsWireless Communications & Telecom Published July 14, 2017Buy ($175)Investing Strategies Published July 11, 2017Buy ($175)Investing Strategies Published June 30, 2017Buy ($175) 






Top Company Interviews






Register for a Free Account to gain greater access to
            The Wall Street Transcript right now




CEO INTERVIEWSInterview with the President and CEO: Lumos Networks Corp. (NASDAQ:LMOS)Interview with the Corporate VP of Business Development, Strategy and Investor Relations: DSP Group, Inc. (NASDAQ:DSPG)Interview with the CEO and Director: Tactile Systems Technology, Inc. (NASDAQ:TCMD) 

SECTOR ROUNDTABLESNatural Gas Weighs Heavy On E&P Near-Term ProspectsRoundtable Forum:optimism Despite Uncertainty In For-profit EducationRoundtable Forum:a Shift In Focus To Natural Gas From Oil 

MONEY MANAGER INTERVIEWSDelivering Long-Term Results with a Risk-Managed Growth FundFinding Investments with Favorable Risk and Reward OpportunitiesBetter Returns and Lower Risk in the Midcap Space 

ANALYST INTERVIEWSAnalyzing the Secular Drivers Within Communications Infrastructure and TelecomSatellite Companies Benefiting from Growth in Data TrafficIncreased Focus on Content as Consumers Shift to Digital Consumption 




Subscribe Today!







                Since 1963
                © The Wall Street Transcript 1997-2016
Terms and Conditions
Privacy Policy  
            





https://www.twst.com/wp-admin/admin-ajax.php

Pin It on Pinterest





































Share This





Twitter





Facebook





Google+





Gmail





LinkedIn








































×





Join now for free!
Already a member?






First Name 





Last Name 





Email address *








Create new account
 


or create an account with a social network.

Join with Facebook


Join with Twitter


Join with Google








Username or Email address: *





Password: *






LoginJoin now! | Forgot password?
 


or login using a social network


Log in with Facebook


Log in with Twitter


Log in with Google












   Joseph Keegan | Molecular Devices Corporation | ZoomInfo.com



Division of Oncology Products 2 (DOP2)





















































  


Skip to main page content
Skip to search
Skip to topics menu
Skip to common links




 
 







HHS
U.S. Department of Health and Human Services

 




  U.S. Food and Drug Administration

 
 




A to Z Index
Follow FDA
En Español


 




Search FDA


Submit search














 
 
 
 










About FDA






 

 






Home
About FDA
FDA Organization

Office of Medical Products and Tobacco

About the Center for Drug Evaluation and Research











Division of Oncology Products 2 (DOP2)





Share


Tweet


Linkedin


Pin it


More sharing options


Linkedin


Pin it




Email


Print






Director: Patricia Keegan, M.D.Deputy Director: Joseph Gootenberg, M.D.Associate Deputy Director: Martha Donoghue (Acting)Deputy Director of Safety: Jeffrey Summers, M.D.SRPM: Karen HennessyChief, Project Management Staff: Melanie PierceChief, Project Management Staff: Monica Hughes The Division of Oncology Products 2 (DOP2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas:Gastrointestinal CancersLung/Head & Neck CancersNeuro-oncology/Rare cancers/Pediatric Solid TumorMelanoma/SarcomaMailing Address:Food and Drug AdministrationCenter for Drug Evaluation and ResearchDivision of Oncology Products 2 (DOP2)5901-B Ammendale RoadBeltsville, MD 20705-1266Phone: (301) 796-2320Fax: (301) 796-9849











More in About the Center for Drug Evaluation and Research
CDER Offices and Divisions
Drug Safety Oversight Board
Jobs at the Center for Drug Evaluation and Research (CDER)
Meeting Presentations (Drugs)
CDER Exclusivity Board

FAQs about CDER

Reports & Budgets (CDER)
Annual CDER Reports to Congress

Manual of Policies & Procedures (CDER)

Contact CDER
CDER Formal Dispute Resolution
The CDER Reference Guide
CDER Ombudsman

 

Resources for You
Office of Hematology and Oncology Products (OHOP)

Office of Hematology Oncology Products (OHOP) Divisions and Programs



 















	Page Last Updated: 02/28/2017


	Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
   Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English






 























Board of Directors - Tim Hoerr, Nina Saberi, Joseph D. Keegan

















































 













844.892.7729
sales@nanomedicaldiagnostics.com
 


0 Items
  
 
 












Select Page


  
 



 



 










 


Tim Hoerr, CPA, CMA
Tim Hoerr is a seasoned business executive with over 30 years of experience in a variety of industries. He serves as the CEO and President of Serra Ventures, a consultancy offering professional services to emerging technology enterprises, and Principal of Serra Capital, a firm providing seed, emerging and growth capital to high technology companies. Tim has worked in the University of Illinois at Urbana-Champaign (“UIUC”) technology community since 2001 and is a charter member of the University’s Entrepreneur-in-Residence program at EnterpriseWorks business incubator in the Research Park. He was co-founder and former CEO of iCyt Mission Technology, Inc., a highly successful bio-instrument company that has won numerous awards for technology and business excellence and which was acquired by Sony Corporation in late 2009. Tim was awarded the Entrepreneurial Excellence in Management Award at the Innovation Celebration, 2009. Since 1983 he has assisted over 500 organizations to achieve high performance by providing strategic, operational and leadership consulting. Tim spent nearly all of the first 15 years of his professional career with RSM McGladrey in Illinois and San Diego, leading teams of consultants focused on serving middle market clients. In his capacity as Consulting Partner with McGladrey, Tim provided leadership on a regional and national level. He also served on two national committees for the American Society of Certified Public Accountants (Business Valuation and Emerging Services). Also a professional author and speaker, he has given over 300 speaking and workshop presentations in his professional career to such diverse groups as Nabisco, Buck Knives, SaabCars USA, and Nationalease. Tim holds the Certified Public Accountant (CPA, 1983) and Certified Management Accountant (CMA, 1984) designations. He received national honors on both the CPA and CMA examinations. He formerly held the Accredited Senior Appraiser of Business Valuation credential (American Society of Appraisers) while actively practicing business valuation as a partner in RSM McGladrey. Mr. Hoerr has a B.S. in Accounting and a B.S. in Business Admin. From Illinois State University, summa cum laude, graduating in 1983. Mr. Hoerr is on the boards of Baylor University Technology Entrepreneurship Initiative (2009 to present), Urbana-Champaign Angel Network (Chairman, 2010 to present), Vineyard Church Pastoral Advisory Council (2012 to present), and Champaign County Economic Development Corporation (2004 to 2012).

 
 
 




 


Nina Saberi
As an industry veteran with extensive investment and operational experience, Nina Saberi brings deep business expertise and hands-on management experience to a new generation of impactful entrepreneurial businesses. Ms. Saberi currently serves on the boards of Agiliance, Connotate, Funambol, and NanoMedical Diagnostics operating in the mobile/enterprise infrastructure, Cloud, security, and medical devices markets. Ms. Saberi joined the venture community as a general partner at OneLiberty Ventures. She then founded Castile Ventures where, under her leadership, Castile raised hundreds of millions of dollars in multiple funds and partnered with innovative and successful entrepreneurs to become a highly respected top ranking early stage Venture firm. Ms. Saberi served many of the portfolio companies as the chairman of the board, founding VC, lead director or investor. These companies are now public (Sonus Networks), or operating as part of acquiring companies including: Thermo Fisher (Ahura Scientific), Symantec/PGP (ChosenSecurity), EMC (Network Intelligence), NetScout (Quantiva), Belden (Trapeze Networks), Pace (Aurora Networks), VeriSign (GeoTrust), Vecna (VGo Communications), thinkingphones (Whaleback), C-Cor (Stargus), Logility (Optiant), and EXFO (Brix).During her operating career, Ms. Saberi was president and CEO of venture-backed Netlink, which was acquired by Cabletron as one of the top three acquisitions of its year. She also successfully led Amnet to its acquisition, managed an international joint venture for Data General and Singapore Telecom and held executive marketing and engineering positions at BBN and Avanti Communications. In 2010, Ms. Saberi was recognized by AlwaysOn as one of the top VCs in the East, and in 2006 by Mass High Tech as an All Star in Finance. She is the Chairman Emeritus of the Massachusetts Technology Leadership Council (formerly known as the Massachusetts Network Communications Council) and has served on the President’s Advisory Council at the University of Rhode Island where she received her BS in Electrical Engineering. In 2007, URI honored Ms. Saberi with the President’s Distinguished Achievement Award.

 
 
 




 


Joseph D. Keegan, PH.D.
Dr. Keegan has more than 30 years of experience in life science businesses. As CEO at ForteBio, Inc. he led the Series C financing which raised $25M, established product development and sales strategies that resulted in 2007-11 compounded annual revenue growth of 45% to $27M , and exited the company in 2012 through its sale to Pall Corporation for a return to investors of $160M. During his 9 year tenure as CEO at Molecular Devices Corporation, Dr. Keegan grew the company’s revenues from $30M to $185M through internal growth and acquisitions. In early 2007, he oversaw its acquisition by MDS Corporation for $615M. Dr. Keegan joined MDC from Becton Dickinson and Company where he served as President of Worldwide Tissue Culture and Vice President, General Manager of Worldwide Flow Cytometry. Prior to Becton Dickinson, Dr. Keegan was Vice President of the Microscopy and Scientific Instruments Division of Leica, Inc. He currently serves on the Boards of Directors of  Courtagen Life Sciences, Interpace Diagnostics Inc. (NASDAQ: IDGX),  Labcyte Corporation as Chairman, Optofluidics, Inc.,  Response Biomedical Corporation (RBM:Toronto), Unchained Labs, Inc.,  Wasatch Microfluidics, Inc., and the San Francisco Opera. Dr. Keegan holds a B.A. in Chemistry from Boston University and a Ph.D. in Physical Chemistry from Stanford University.

 
 
 




 


Brett Goldsmith, Ph.D.
A founding member of Nanomed and the company’s CTO, Dr. Goldsmith’s passion is taking nanoelectronic technology out of the theoretical realm to create practical products.  One of the few people in the world with the combined expertise in biology and nanotechnology needed to develop graphene as a viable bio-electronic device, Dr. Goldsmith was the lead researcher on landmark field effect biosensing papers in Science and Nature Nanotechnology.  His early work established coupling of biochemical systems to carbon nanotubes, for which he won the Nottingham Prize from the Physical Electronics Conference. Following graduate school at UC Irvine, Dr. Goldsmith joined the University of Pennsylvania as an Intelligence Community Fellow and led a project developing electronic devices coupled with GPCRs for multiplexed small molecule sensing. Leaving his post-doc position to start a nanotechnology group at the Navy’s San Diego laboratory, Dr. Goldsmith identified technological needs in the field and advanced nanotechnology solutions to those needs through partnership with programs including Living Foundries and IVN Dx. Dr. Goldsmith brings to Nanomed proven experience in applying technological advancements in materials and electronics to biomedical needs.

 
 
 




 


Ross Bundy
A founding member of Nanomed and the company’s CEO, Ross is a graduate of UCSD with an MBA from SDSU. Ross’s passion is precision execution, and he applies this to driving company direction and operations, raising capital funding, and developing strategic collaborations and partnerships. Ross brings business development, supply chain, finance, and operations expertise from 13 years of experience in industries ranging from consumer goods to defense manufacturing to financial services. At Bumble Bee Foods, Ross created and implemented cross-functional supply chain procedures that reduced processing hours while improving scheduling accuracy and decreasing cost. Prior to Bumble Bee at General Dynamics, Ross identified and negotiated business development projects that gained the company new opportunities in alternative energy, commercial construction, and heavy tool manufacturing. At UBS Financial Services, Ross created financial models to estimate future growth rates. Ross brings a demonstrated track record of successful implementation and a well-rounded background to his role as CEO of Nanomed.

 
 
 
 
 
 
 

 
 
 



























JOSEPH D  KEEGAN - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











JOSEPH D  KEEGAN
Check out list of companies and businesses related to JOSEPH D  KEEGAN. Find out JOSEPH D  KEEGAN address and contact details. View other people related to JOSEPH D  KEEGAN - coworkers, colleagues, companions, etc.
Address:   

1311 ORLEANS DRIVE  SUNNYVALE 94089 CA




Companies related to JOSEPH D  KEEGAN
CIKCompany NamePositionCompany Address0000806888RESPONSE BIOMEDICAL CORPDirector 1781 - 75TH AVENUE W.  VANCOUVER V6P6P20001003113MOLECULAR DEVICES CORPCEO/President 1311 ORLEANS DR  SUNNYVALE 940890001054102Interpace Diagnostics Group, Inc.Director MORRIS CORPORATE CENTER 1, BUILDING A, 300 INTERPACE PARKWAY PARSIPPANY 070540001289340Stereotaxis, Inc.Director 4320 FOREST PARK AVENUE SUITE 100 ST.LOUIS 63108




JOSEPH D  KEEGAN on the Web
Persons related to JOSEPH D  KEEGAN - RESPONSE BIOMEDICAL CORPNamePositionCityWilliam J.  AdamsCFO & Corporate Secretary VANCOUVERTsonis  AnastasiosVancouverTsonis  AnastasiosVancouverHoller  AnthonyVancouverHoller  AnthonyVancouverHoller  AnthonyVancouverHoller  AnthonyVancouverRichard  CanoteVANCOUVERSeverson  ClintVancouverSeverson  ClintVancouverSeverson  ClintonVancouverWang  DavidVancouverAnthony  Holler  Dr.VancouverAnthony  Holler  Dr.VancouverDavid  Wang  Dr.VancouverDavid  Wang  Dr.VancouverJoseph  Keegan  Dr.VancouverJoseph  Keegan  Dr.VancouverPeter  Thompson  Dr.VancouverPeter  Thompson  Dr.VancouverMorris  DuaneVancouverMorris  DuaneVancouverMorris  DuaneVancouverLiming  FuHANGZHOU, ZHEJIANG CHINAHangzhou Joinstar Medical Instrument & Reagent Co. Ltd.HANGZHOU, ZHEJIANG CHINAHangzhou Lizhu Medical Instrument & Reagent Co. Ltd.HANGZHOU, ZHEJIANG CHINAANTHONY F  HOLLERDirector VANCOUVERWebb  IanVancouverSAMUEL D  ISALYSAMUEL D  ISALYNEW YORKSAMUEL D  ISALYNEW YORKPurvin  JeffreyVancouverWang  JonathanVancouverKeegan  JosephVancouverJOSEPH D  KEEGANDirector SUNNYVALEJOSEPH D  KEEGANSUNNYVALEJOSEPH D  KEEGANDirector VANCOUVERBarbara  Kinnaird-SteenChief Executive Officer VANCOUVERShuster  LewisVancouverShuster  LewisVancouverShuster  LewisVancouberKaler  LivleenVancouverKaler  LivleenVancouverKaler  LivleenVancouverPatricia  MassittiVP - Admin and Corp Comm VANCOUVERORBIMED ADVISORS LLCDirector ORBIMED ADVISORS LLC10% Owner NEW YORKOrbiMed Advisors LtdNEW YORKOrbiMed Advisors LtdNEW YORKOrbiMed Advisors LtdNEW YORKORBIMED ASIA GP, LPNEW YORKORBIMED ASIA GP, LPNEW YORKORBIMED ASIA GP, LPNEW YORKOrbiMed Capital GP III LLCNEW YORKOrbiMed Capital GP III LLCNEW YORKOrbiMed Capital GP III LLCNEW YORKHarris  PaulVancouverThompson  PeterVancouverThompson  PeterVancouverJEFFREY L  PURVINVANCOUVERBastiani  RichardVancouverBastiani  RichardVancouverBear  RichardVancouverBear  RichardVancouverBastiani  RichardVancouverBear  RichardVancouverKay  S.VancouverKay  S.VancouverKay  S.VancouverCLINTON  SEVERSONDirector CLINTON  SEVERSONDirector VANCOUVERTimothy Patrick  ShannonVANCOUVERTimothy Patrick  ShannonSrVPWorldWideSales&Marketing VANCOUVERLewis  ShusterDirector SAN DIEGOLewis  ShusterDirector VANCOUVERPeter A  ThompsonDirector BELLEVUEPeter A.  ThompsonDirector VANCOUVERPatrick  ToddVancouverPatrick  ToddVancouverPatrick  ToddVancouverAnastasios  TsonisController VANCOUVERDavid  WangDirector VANCOUVERJonathan Jian  WangDirector VANCOUVERAdams  WilliamVancouverWenjie  XuHANGZHOU, ZHEJIANG CHINAXuyi  ZhouHANGZHOU, ZHEJIANG CHINAPersons related to JOSEPH D  KEEGAN - MOLECULAR DEVICES CORPNamePositionCityMOSHE  ALAFIMOSHE  ALAFIDirector SUNNYVALEMOSHE  ALAFIDirector SUNNYVALEDAVID L  ANDERSONDAVID L  ANDERSONDirector SUNNYVALEDAVID L  ANDERSONDirector SUNNYVALEA BLAINE  BOWMANA BLAINE  BOWMANDirector SUNNYVALEA BLAINE  BOWMANDirector SUNNYVALESteve  DavenportVP European Operations SUNNYVALEAlan  FinkelCTO/Sr Vice President SUNNYVALEAlan  FinkelCTO/Sr Vice President SUNNYVALEPAUL  GODDARDPAUL  GODDARDDirector SUNNYVALETIMOTHY  HARKNESSCFO/VP Finance SUNNYVALEJan  HughesVP Marketing SUNNYVALEGILLIAN M K  HUMPHRIESGILLIAN M K  HUMPHRIESVP Strategic Affairs SUNNYVALEJOSEPH D  KEEGANCEO/President SUNNYVALEJOSEPH D  KEEGANCEO/President SUNNYVALEANDRE F  MARIONANDRE F  MARIONDirector SUNNYVALEANDRE F  MARIONDirector SUNNYVALEHARDEN M  MCCONNELLHARDEN M  MCCONNELLDirector SUNNYVALEMOLECULAR DEVICES CORPSUNNYVALEROBERT JOSEPH  MURRAYVP Operations SUNNYVALESTEPHEN J  OLDFIELDVP Marketing SUNNYVALETHOMAS J  OLENICVP Sales and Service SUNNYVALEPATRICIA  SHARPVP Human Resource SUNNYVALEJ RICHARD  SPORTSMANVP Assay & Reagent SUNNYVALEJ ALLAN  WAITZJ ALLAN  WAITZDirector SUNNYVALEJ ALLAN  WAITZDirector SUNNYVALERobert H  WickeVice Pres. Product Development SUNNYVALEANDREW T  ZANDERVP Engineering SUNNYVALEPersons related to JOSEPH D  KEEGAN - Interpace Diagnostics Group, Inc.NamePositionCityGerald P.  BelleDirector SALT LAKE CITYGerald P.  BelleDirector SADDLE RIVERGerald P.  BelleDirector PARSIPPANYBERNARD C  BOYLEChief Financial Officer UPPER SADDLE RIVERBERNARD C  BOYLEChief Financial Officer SADDLE RIVERSTEVEN K  BUDDPresident UPPER SADDLE RIVERSTEVEN K  BUDDPresident SADDLE RIVERSTEVEN K  BUDDPresident SADDLE RIVERKevin  ConnollySADDLE RIVERKevin  ConnollyExecutive Vice President SADDLE RIVERKevin  ConnollyExecutive vice-president SADDLE RIVERKevin  ConnollyEVP, Marketing Services SADDLE RIVERSTEPHEN  COTUGNOExecutive Vice President UPPER SADDLE RIVERSTEPHEN  COTUGNOExecutive Vice President SADDLE RIVERSTEPHEN  COTUGNOExecutive Vice-President SADDLE RIVERJOSEPH I  CURTIDirector UPPER SADDLE RIVERJOSEPH I  CURTIDirector SADDLE RIVERJOSEPH I  CURTIDirector SADDLE RIVERJOSEPH I  CURTIDirector SADDLE RIVERJack  DavisPARSIPPANYHoward  DraznerSADDLE RIVERHoward  DraznerSVP,Bus. Dev Medical Education PARSIPPANYHeiner  DreismannDirector SAN DIEGOHeiner  DreismannDirector PARSIPPANYJOHN P  DUGANChairman of the Board UPPER SADDLE RIVERJames  EarlyChief Financial Officer PARSIPPANYLARRY  ELLBERGERDirector UPPER SADDLE RIVERLARRY  ELLBERGERDirector SADDLE RIVERLARRY  ELLBERGERChief Executive Officer SADDLE RIVERJames G.  FarrellVP, Corporate Controller SADDLE RIVERJOHN  FEDERSPIELDirector UPPER SADDLE RIVERJOHN  FEDERSPIELDirector SADDLE RIVERJOHN  FEDERSPIELDirector SADDLE RIVERJOHN  FEDERSPIELDirector SADDLE RIVERJOHN  FEDERSPIELDirector PARSIPPANYHarry  GlorikianDirector PARSIPPANYHEARTLAND ADVISORS INCMILWAUKEEStover  JackParsippanyBETH  JACOBSONExec. V.P. & General Counsel UPPER SADDLE RIVERBETH  JACOBSONExecutive Vice President SADDLE RIVERBETH  JACOBSONFormer Exec VP & GC SADDLE RIVEREarly  JamesParsippanyKeegan  JosephParsippanyJOSEPH D  KEEGANDirector SUNNYVALEDavid E  KerrSADDLE RIVERDavid E  KerrSenior VP Business Development PARSIPPANYNat  KrishnamurtiInterim CFO SOMERSETRobert Owen  LikoffPARSIPPANYVERONICA  LUBATKINDirector SADDLE RIVERVERONICA  LUBATKINDirector PARSIPPANYNancy  LurkerCEO SADDLE RIVERNancy  LurkerCEO SADDLE RIVERNancy  LurkerCEO PARSIPPANYMichael  MarquardSADDLE RIVERMichael  MarquardCEO SADDLE RIVERMichael  MarquardCEO SADDLE RIVERNancy  McCarthyEVP, Human Resources SADDLE RIVERNancy  McCarthyExecutive Vice President SADDLE RIVERNancy  McCarthyEVP, Human Resources SADDLE RIVERNancy  McCarthyEVP, Human Resources SADDLE RIVERGerald R  Melillo JRPresident, Sales Services PARSIPPANYGraham G  MiaoCFO NEW YORKGraham G  MiaoCFO PARSIPPANYRichard P  MicaliSADDLE RIVERRichard P  MicaliSenior VP, Sales Services PARSIPPANYGERALD J  MOSSINGHOFFUPPER SADDLE RIVERWILLIAM J  NASGOVITZMILWAUKEEJOHN M  PIETRUSKIUPPER SADDLE RIVERJOHN M  PIETRUSKIDirector UPPER SADDLE RIVERJOHN M  PIETRUSKIDirector SADDLE RIVERJOHN M  PIETRUSKIDirector SADDLE RIVERJOHN M  PIETRUSKIDirector SADDLE RIVERKapila  RatnamPARSIPPANYFRANK J  RYANDirector UPPER SADDLE RIVERFRANK J  RYANDirector SADDLE RIVERFRANK J  RYANDirector SADDLE RIVERFRANK J  RYANDirector SADDLE RIVERFRANK J  RYANDirector PARSIPPANYJo Ann  SaittaSVP and CIO, GM GROUP DCA PARSIPPANYCHARLES T  SALDARINIVice Chair of Board & CEO UPPER SADDLE RIVERCHARLES T  SALDARINIVice Chairman of Board and CEO SADDLE RIVERCHARLES T  SALDARINIVice Chairman, Chief Exec Off. SADDLE RIVERDEBORAH  SCHNELLEVP Business Development UPPER SADDLE RIVERJeffrey Edward  SmithWESTFIELDJeffrey Edward  SmithCFO SADDLE RIVERJeffrey Edward  SmithVP of Corporate Development PARSIPPANYSullivan  StephenParsippanyJACK E  STOVERPresident and CEO EXTONJACK E  STOVERDirector PARSIPPANYJACK E  STOVERDirector SADDLE RIVERJACK E  STOVERDirector SADDLE RIVERSTEPHEN J  SULLIVANDirector PRINCETONSTEPHEN J  SULLIVANDirector SADDLE RIVERSTEPHEN J  SULLIVANDirector SADDLE RIVERSTEPHEN J  SULLIVANDirector SADDLE RIVERSTEPHEN J  SULLIVANDirector SADDLE RIVERSTEPHEN J  SULLIVANDirector PARSIPPANYCHRISTOPHER  TAMAExecutive Vice President UPPER SADDLE RIVERCHRISTOPHER  TAMAExecutive Vice President SADDLE RIVERPeter  TillesSADDLE RIVERJAN MARTENS  VECSIDirector UPPER SADDLE RIVERJAN MARTENS  VECSIDirector SADDLE RIVERJAN MARTENS  VECSIDirector SADDLE RIVERJAN MARTENS  VECSIDirector SADDLE RIVERJAN MARTENS  VECSIDirector PARSIPPANYPersons related to JOSEPH D  KEEGAN - Stereotaxis, Inc.NamePositionCityABHI  ACHARYADirector SARATOGAABHI  ACHARYADirector SARATOGAALAFI CAPITAL CO LLC10% Owner BERKELEYALAFI CAPITAL CO LLC10% Owner BERKELEYChristopher D  Alafi10% Owner BERKELEYChristopher D  AlafiDirector BERKELEYMOSHE  ALAFI10% Owner BERKELEYMOSHE  ALAFI10% Owner BERKELEYJOHN C  APLINDirector INDIANAPOLISMenawat  ArunSt. LouisDavid  BenferDirector BRANFORDDavid  BenferDirector BRANFORDDavid  BenferDirector LAKEWOOD RANCHDavid  BenferDirector ST. LOUISPaul  BrathwaiteVP Research & Development ST. LOUISDouglas Michael  BruceST. LOUISDouglas Michael  BruceSr. V.P., R & D ST. LOUISDouglas Michael  BruceSr. VP, R&D ST.LOUISDouglas Michael  BruceChief Tech./Operations Officer ST.LOUISDouglas Michael  BruceChief Tech./Operations Officer ST. LOUISDouglas Michael  BruceChief Tech./Operations Officer ST LOUISFrank  ChengSenior VP, Marketing and BD ST. LOUISAlafi  ChristopherSt. LouisRalph G  Dacey JrDirector ST. LOUISGiffen  DavidSt. LouisGiffin  DavidSt. LouisFischel  DavidSt. LouisBenfer  DavidSt. LouisDuane  DeSistoDirector BEDFORDDeSisto  DuaneSt. LouisSamuel W  Duggan IIChief Financial Officer ST. LOUISKaren Witte  DurosSr. VP, Gen. Counsel and Sec. ST. LOUISPrystowsky  EricSt. LouisDavid Leo  FischelDirector ST. LOUISNathan  FischelDirector ST. LOUISCheng  FrankSt. LouisMiddleton  FredSt. LouisDavid  GiffinVP, Human Resources ST. LOUISDavid  GiffinVP, Human Resources ST LOUISLUKE  HARADASr. VP, Business Development ST. LOUISBevil J  HoggST. LOUISBevil J  HoggPresident & CEO ST. LOUISBevil J  HoggDirector ST. LOUISGregory R  JohnsonDirector ST. LOUISGregory R  JohnsonDirector ST. LOUISGregory R  JohnsonDirector ST.LOUISDANIEL J  JOHNSTONST. LOUISDANIEL J  JOHNSTONCFO ST. LOUISDANIEL J  JOHNSTONCFO ST LOUISKeegan  JosephSt. LouisKiani  JosephSt. LouisMichael P  KaminskiChief Operating Officer ST. LOUISMichael P  KaminskiChief Operating Officer ST. LOUISMichael P  KaminskiPresident & CEO ST. LOUISMichael P  KaminskiPresident and CEO ST. LOUISMichael P  KaminskiPresident and CEO ST LOUISDuros  KarenSt. LouisJOSEPH D  KEEGANDirector SUNNYVALEJOSEPH D  KEEGANDirector ST LOUISJOSEPH D  KEEGANDirector ST. LOUISWilliam M  KelleyBATESVILLEWilliam M  KelleyDirector BATESVILLEWilliam M  KelleyDirector BATESVILLEWilliam M  KelleyDirector BATESVILLEWilliam M  KelleyDirector BATESVILLEJOE E  KIANIDirector REDWOOD SHORESRandall D  LedfordST. LOUISAbhijeet J  LeleWEST BERLINAbhijeet J  LeleDirector ROWAYTONAbhijeet J  LeleDirector NEW YORKStammer  MartinSt. LouisArun Swarup  MenawatDirector ST. LOUISROBERT J  MESSEYDirector ROBERT J  MESSEYDirector ST. LOUISROBERT J  MESSEYDirector ST LOUISROBERT J  MESSEYDirector ST. LOUISKaminski  MichaelSt. LouisFRED A  MIDDLETONDirector SAN MATEOFRED A  MIDDLETONDirector SAN MATEOFRED A  MIDDLETONDirector SAN MATEOFRED A  MIDDLETONDirector ST. LOUISFRED A  MIDDLETONDirector SAN MATEOWilliam C.  Mills IIIChief Executive Officer CARLISLEWilliam C.  Mills IIIDirector CARLISLEWilliam C.  Mills IIIDirector CARLISLEWilliam C.  Mills IIIChief Executive Officer ST. LOUISDavid J  ParkerDirector WELLESLEYDavid J  ParkerDirector WELLESLEYBrathwaite  PaulSt. LouisERIC N  PRYSTOWSKYDirector INDIANAPOLISERIC N  PRYSTOWSKYDirector ST. LOUISMessey  RobertSt. LouisLOUIS T  RUGGIEROChief Commercial Officer ST. LOUISDuggan  SamuelSt. LouisSANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP10% Owner SAN MATEORuchir  SehraVP of Clinical Affairs ST. LOUISRuchir  SehraChief Medical Officer ST. LOUISKEVIN T  SHIFRINSr. VP, Marketing & Bus. Dev. ST. LOUISKEVIN T  SHIFRINSr. VP, Marketing & Bus. Dev. ST. LOUISMartin C  StammerChief Financial Officer ST. LOUISJAMES M  STOLZEST. LOUISJAMES M  STOLZEVP & CFO ST LOUISJAMES M  STOLZEV.P. & CFO ST LOUISEuan  ThomsonDirector SUNNYVALEEuan  ThomsonDirector ST. LOUISEuan  ThomsonST. LOUISMelissa  WalkerVP, Regulatory & Quality WILDWOODMelissa  WalkerSr. VP, Reg., Quality & Comp. ST. LOUISMills  WilliamSt. LouisMills  William IIISt. LouisKelley  WilliamSt. Louis












 






